Search Press releases Keywords From To 22 Apr 2021 UCB’s zilucoplan shows no relevant effect in immune-mediated necrotizing myopathy (IMNM) Read More 20 Apr 2021 Acquisitions of own shares and Disposals of own shares Read More 16 Apr 2021 UCB showcases new research at the 73rd American Academy of Neurology Annual Meeting to demonstrate broad neurology leadership and future portfolio Read More 14 Apr 2021 Notice of Early Redemption - €350 million € 1.875% fixed rate notes due 2 April 2022 Read More 9 Apr 2021 Acquisitions of own shares and Disposals of own shares Read More 7 Apr 2021 Transparency notification UCB SA/NV Read More Pagination First page Previous page Previous … Page 55 Page 56 Page 57 Page 58 Current page 59 Page 60 Page 61 Page 62 Page 63 Page 59 of 63 Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
